Primobolan Overview, Dosing & Safety | Peptide Database

Primobolan (Primo)

Anabolic Steroid | Lean Mass & Low Side Effect Profile

Community Research

Join others researching Primobolan — share findings, ask questions, and learn from real experiences

Primobolan (metenolone) is a dihydrotestosterone (DHT)-derived anabolic steroid that has been in clinical and performance use since the 1960s. It was originally marketed by Schering as Primobolan (oral acetate) and Primobolan Depot (injectable enanthate) for the treatment of muscle wasting diseases, malnutrition, and osteoporosis. Although it was once FDA-approved in the United States, it has since been discontinued from the US market and is primarily available through international pharmacies and underground production. Primobolan is widely considered one of the mildest and safest anabolic steroids in terms of side effect profile. It does not aromatize to estrogen, carries low androgenic activity relative to its anabolic effects (anabolic-to-androgenic ratio of approximately 88:44 compared to testosterone at 100:100), and the injectable form is not hepatotoxic. It gained legendary status in golden-era bodybuilding, with Arnold Schwarzenegger reportedly favoring it as part of his competition preparation. Primobolan is particularly valued for lean tissue preservation during caloric deficits, quality muscle gains without water retention, and its compatibility with longer cycle durations due to its mild nature. Its primary drawback is cost -- it is one of the most expensive anabolic steroids per milligram, and effective doses require relatively high volumes of oil for injection.

Metenolone binds to the androgen receptor (AR) to promote nitrogen retention, protein synthesis, and anti-catabolic effects in skeletal muscle tissue. As a DHT derivative, it cannot be aromatized by the aromatase enzyme, meaning it produces no estrogenic metabolites and does not contribute to water retention, gynecomastia, or estrogen-mediated fat gain. Unlike testosterone, which is converted to the more potent DHT by 5-alpha reductase, metenolone is already a DHT derivative and undergoes no further activation in androgen-sensitive tissues, resulting in a relatively mild androgenic profile. Metenolone has a strong affinity for androgen receptors in muscle tissue and exerts significant anti-catabolic effects by reducing glucocorticoid receptor expression and inhibiting cortisol-mediated protein breakdown. This makes it particularly effective during caloric restriction, where it helps preserve lean tissue. It also enhances immune function at moderate doses, which was one of its original clinical applications in immunocompromised patients. The injectable enanthate form bypasses hepatic first-pass metabolism entirely, making it non-hepatotoxic. The oral acetate form, while possessing a 1-methyl modification that provides some degree of oral bioavailability, is not 17-alpha-alkylated in the traditional sense but still exerts measurable hepatic stress at sustained doses.

Molecular Data

Research Indications

Primobolan's primary strength lies in its anti-catabolic properties during energy restriction. It significantly reduces muscle protein breakdown by modulating glucocorticoid receptor activity, making it a preferred compound for contest preparation and body recomposition phases where preserving lean tissue while losing fat is the primary objective.

Primobolan produces moderate but high-quality muscle gains without water retention. Gains are slower and less dramatic than with more potent anabolic steroids but are more easily retained after discontinuation. Milligram-for-milligram it is less potent than testosterone, nandrolone, or trenbolone for mass building.

The combination of anti-catabolic effects, zero aromatization, and moderate anabolic activity makes primobolan well-suited for simultaneous fat loss and lean tissue maintenance or modest gain, particularly when combined with a testosterone base.

Originally prescribed for muscle wasting conditions, sarcopenia, and post-surgical recovery. Metenolone's mild side effect profile made it suitable for debilitated patients, including women and children, at conservative therapeutic doses.

Historical clinical application for bone mineral density preservation, particularly in postmenopausal women. Its non-aromatizing nature and low androgenic activity made it a more tolerable option than other anabolic steroids for female patients.

Metenolone was used clinically to support immune function in immunocompromised patients, including those with AIDS-related wasting. It has demonstrated the ability to enhance T-cell counts and immune competence at moderate doses.

Dosing Protocols

Primobolan Depot (metenolone enanthate) is administered via intramuscular injection. The enanthate ester provides a half-life of approximately 10 days, allowing for once or twice weekly injection schedules. The injectable form is not hepatotoxic and is the strongly preferred route of administration for both efficacy and safety. Due to metenolone's relatively low potency per milligram, effective performance doses require injecting larger volumes of oil (typically 2-4 mL per injection at standard 100 mg/mL concentration), which is a practical consideration.

Lean Mass Preservation - Cutting

400-600 mg/week

2x per week (split dose)

Intramuscular

Lean Bulking

600-800 mg/week

Female Protocol

50-100 mg/week

1x per week

Reconstitution Instructions

Pre-filled metenolone enanthate vial (typically 100 mg/mL in sesame or grape seed oil)

Syringes (3 mL preferred due to larger injection volumes)

Drawing needle (18-21 gauge)

Injection needle (22-25 gauge for IM)

Alcohol swabs

Sharps container

1 Wash hands thoroughly and prepare a clean work surface

2 Wipe vial stopper with alcohol swab and allow to dry

3 Draw air into syringe equal to the volume of oil to be withdrawn

4 Insert drawing needle through vial stopper and inject air to equalize pressure

5 Invert vial and withdraw the prescribed dose, tapping to remove air bubbles

6 Switch to injection needle (do not inject with drawing needle)

7 Clean injection site with alcohol swab in circular motion outward

8 Insert needle at 90-degree angle into ventrogluteal, vastus lateralis, or deltoid muscle

9 Aspirate briefly (optional per current guidelines), then inject slowly over 15-30 seconds

10 Withdraw needle, apply gentle pressure with gauze, dispose of needle in sharps container

Protocol Variations

Multiple approaches exist - compare before choosing

Different sources recommend different protocols for this peptide. Review each approach and consider your goals, tolerance, and experience level before choosing.

Metenolone Enanthate (Primobolan Depot)

Source: Standard Injectable Protocol

"The injectable enanthate ester is the preferred form for performance and therapeutic use. Non-hepatotoxic, longer-acting, and more cost-effective per equivalent dose than oral acetate."

Metenolone enanthate is a long-acting injectable formulation with a half-life of approximately 10 days. It is the standard and strongly preferred form for both clinical and performance applications. The enanthate ester bypasses hepatic first-pass metabolism entirely, eliminating liver toxicity concerns and allowing for extended cycle durations of 12-20 weeks. Typical concentrations are 100 mg/mL, though some underground labs produce 200 mg/mL formulations.

Key Points

Half-life: ~10 days -- supports once or twice weekly injection schedules

Non-hepatotoxic -- safe for extended cycle durations

More cost-effective per effective dose compared to oral acetate

Requires larger injection volumes due to typical 100 mg/mL concentration

Slower onset with steady-state blood levels achieved in approximately 4-5 weeks

Dosing Schedule

Metenolone Acetate (Oral Primobolan)

Source: Oral Protocol

"Short-acting oral form suited to those who prefer not to inject or who want rapid clearance. Less efficient and more hepatotoxic than the injectable, but offers dose flexibility."

Metenolone acetate is the oral formulation with a half-life of approximately 4 hours. It possesses a 1-methyl modification that provides partial oral bioavailability, but it is not 17-alpha-alkylated, making it less hepatotoxic than most oral anabolic steroids. However, sustained daily dosing does produce measurable liver enzyme elevations, and cycle lengths should be limited accordingly. Oral primobolan is considerably less potent milligram-for-milligram than the injectable form and is substantially more expensive per equivalent effect.

Half-life: ~4 hours -- requires twice daily dosing for stable levels

Mild hepatotoxicity -- limit cycles to 6-8 weeks

Lower bioavailability means higher mg doses needed for equivalent effect

Significantly more expensive per effective dose than injectable

Rapid clearance can be advantageous for drug testing or managing side effects

Preferred by some female users for the ability to stop quickly if virilization occurs

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Suppression of natural testosterone production (dose-dependent, less suppressive than many other anabolic steroids but still significant)

Hair thinning or accelerated male pattern baldness (DHT derivative -- this is the most commonly reported side effect in susceptible individuals)

Adverse lipid changes, particularly HDL suppression (moderate compared to other anabolic steroids)

Mild acne or oily skin (less pronounced than testosterone or other androgens)

Injection site discomfort from larger oil volumes required at performance doses

Gradual decline in natural testosterone production requiring post-cycle therapy

Stop Signs - Discontinue if:

Severe chest pain, tightness, or pressure

Sudden shortness of breath or difficulty breathing at rest

Yellowing of skin or eyes (jaundice) -- particularly with oral acetate

Signs of stroke: sudden numbness, confusion, trouble speaking, loss of coordination

Severe or persistent headaches with visual disturbances

Rapid or unexplained hair loss beyond gradual thinning

Women: rapid onset of voice deepening, significant facial hair growth, or menstrual cessation

Contraindications

Prostate cancer (active or history of hormone-sensitive prostate cancer)

Breast cancer in males or females

Pregnancy or potential for pregnancy (teratogenic risk -- fetal virilization)

Severe hepatic impairment (particularly relevant for oral acetate form)

Known hypersensitivity to metenolone or formulation components

Hypercalcemia

Polycythemia (hematocrit above 54% at baseline)

Uncontrolled cardiovascular disease or severe dyslipidemia

Quality Checklist

Good Signs

Clear, pale yellow oil with no visible particles or cloudiness

Pharmaceutical-grade product with valid lot number and manufacturer identification (e.g., Bayer Primobolan Depot)

Proper labeling with concentration (typically 100 mg/mL), ester type (enanthate), and expiration date

Intact rubber stopper and tamper-evident seal

Oil draws smoothly with appropriate viscosity

Consistent with known pharmaceutical packaging for the stated manufacturer

Warning Signs

Underground lab product -- primobolan is one of the most frequently counterfeited steroids due to high raw material cost

Concentration claims above 200 mg/mL (metenolone enanthate has limited solubility at higher concentrations)

Price significantly below market rate (genuine primobolan is expensive; cheap product is likely substituted with another steroid)

Oral tablets without pharmaceutical branding (high counterfeit rate for oral primo)

Vial label with spelling errors, misaligned printing, or unprofessional appearance

Bad Signs

Cloudy, discolored, or particulate-containing solution (contamination risk)

Crashed product (crystallized steroid visible in vial)

Broken or missing tamper-evident seal on vial or tablet blister pack

No labeling, incorrect labeling, or missing expiration date

Product testing reveals a different compound (common substitutions include boldenone undecylenate or testosterone)

Severe post-injection pain, redness, or swelling lasting more than 72 hours

Frequently Asked Questions

Is injectable primobolan worth the high cost compared to other steroids?

For cutting and body recomposition, yes—primobolan's superior anti-catabolic effects and complete lack of water retention make lean gains more valuable per milligram than aromatizing steroids. However, milligram-for-milligram it's weaker than testosterone or trenbolone, requiring higher volumes of oil, which adds to practical costs.

Can women use primobolan safely without virilization?

Primobolan is one of the better-tolerated AAS for women due to its low androgenic activity, but virilization risk is dose-dependent and real. Women typically use 50-100mg/week injected or 25-50mg/day oral with careful monitoring for voice deepening or facial hair—side effects that may not fully reverse.

How long does it take to see results from primobolan?

With the long-acting enanthate ester, steady-state levels take 4-5 weeks, so meaningful strength gains and body composition changes typically appear by week 6-8. This slow onset makes primobolan better suited for 16-20 week cycles rather than shorter runs where faster-acting compounds shine.

Will primobolan help prevent hair loss during a testosterone cycle?

No—primobolan is actually a DHT derivative that can accelerate hair thinning in susceptible individuals. If hair loss is a concern, use finasteride alongside any steroid cycle. Primobolan's non-aromatizing nature provides no estrogenic scalp protection, so DHT sensitivity becomes more relevant.

References

Early clinical documentation of the hepatic effects of various oral anabolic steroids, including metenolone acetate. Found that metenolone acetate, while not 17-alpha-alkylated, could produce mild liver enzyme elevations at sustained therapeutic doses, distinguishing it from the non-hepatotoxic injectable enanthate form.

Established the anabolic-to-androgenic ratio of metenolone and other anabolic steroids in animal models. Demonstrated metenolone's favorable separation of anabolic and androgenic activity, supporting its clinical use in populations where androgenic side effects are undesirable.

Landmark study establishing dose-dependent anabolic effects of supraphysiological androgens on muscle size and strength. While focused on testosterone, this trial provided the foundational framework for understanding anabolic steroid dose-response relationships applicable to DHT derivatives including metenolone.

Review of cardiovascular risks associated with anabolic steroid abuse. Documented that while milder compounds like metenolone carry lower cardiovascular risk per dose than more potent androgens, chronic supraphysiological use of any anabolic steroid poses risks including adverse lipid changes, left ventricular hypertrophy, and sudden cardiac events.

Related Peptides

Testosterone is the standard base compound run alongside primobolan. A 1:1 ratio (e.g., 500 mg test / 500 mg primo per week) is the most common approach. Testosterone provides the androgenic and estrogenic signaling that primobolan lacks, maintaining libido, mood, joint lubrication, and cardiovascular-protective estrogen levels. Some users run testosterone at a lower dose and rely on primobolan's non-aromatizing nature to keep overall estrogen lower during cutting phases.

Aromatase inhibitors are compatible but typically unnecessary when primobolan makes up a significant portion of the total steroid load, since primobolan itself does not aromatize. AI use is dictated entirely by the testosterone dose in the stack. Some users find they can run higher testosterone doses alongside primobolan without needing an AI compared to testosterone alone, as the overall estrogen-to-androgen ratio remains favorable.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.